COVID-19 studies for: C19 studies:  HC QHC Q Vitamin DVitamin D IvermectinIVM LY-CoVLY REGN-COV2REGN RemdesivirRMD
HC Q study #135
Source   PDF   Share   Tweet
See all 143 studies
Post Exposure Prophylaxis study (treated after exposure to the virus)
Polat et al., Medical Journal of Bakirkoy, 16:3, 280-6, doi:10.5222/BMJ.2020.50469 (Peer Reviewed)
Hydroxych loroquine Use on Healthcare Workers Exposed to COVID-19 -A Pandemic Hospital Experience
Small prophylaxis study of 208 healthcare workers in Turkey, 138 with high risk exposure received HC Q, while 70 with low and medium risk exposure did not. COVID-19 cases were lower in the treatment group, relative risk RR 0.43, p = 0.026. Since the control group had lower risk, the actual benefit may be larger.
COVID-19 case, ↓57.0%, p=0.03
Source   PDF   Share   Tweet
See all 143 studies
Please send us corrections, updates, or comments.